Logo image of MEG

MONTROSE ENVIRONMENTAL GROUP (MEG) Stock Fundamental Analysis

NYSE:MEG - US6151111019 - Common Stock

29.36 USD
-0.69 (-2.3%)
Last: 8/25/2025, 8:04:01 PM
29.36 USD
0 (0%)
After Hours: 8/25/2025, 8:04:01 PM
Fundamental Rating

3

MEG gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 84 industry peers in the Commercial Services & Supplies industry. The financial health of MEG is average, but there are quite some concerns on its profitability. MEG is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year MEG has reported negative net income.
MEG had a positive operating cash flow in the past year.
MEG had negative earnings in each of the past 5 years.
Each year in the past 5 years MEG had a positive operating cash flow.
MEG Yearly Net Income VS EBIT VS OCF VS FCFMEG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

MEG has a worse Return On Assets (-4.95%) than 66.67% of its industry peers.
With a Return On Equity value of -9.81%, MEG is not doing good in the industry: 61.90% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -4.95%
ROE -9.81%
ROIC N/A
ROA(3y)-6.43%
ROA(5y)-8.4%
ROE(3y)-11.31%
ROE(5y)-15.93%
ROIC(3y)N/A
ROIC(5y)N/A
MEG Yearly ROA, ROE, ROICMEG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

Looking at the Gross Margin, with a value of 41.19%, MEG is in the better half of the industry, outperforming 70.24% of the companies in the same industry.
In the last couple of years the Gross Margin of MEG has grown nicely.
MEG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.16%
GM growth 5Y5.98%
MEG Yearly Profit, Operating, Gross MarginsMEG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

4

2. Health

2.1 Basic Checks

MEG does not have a ROIC to compare to the WACC, probably because it is not profitable.
MEG has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MEG has been increased compared to 5 years ago.
MEG has a worse debt/assets ratio than last year.
MEG Yearly Shares OutstandingMEG Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MEG Yearly Total Debt VS Total AssetsMEG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 1.78, we must say that MEG is in the distress zone and has some risk of bankruptcy.
MEG has a Altman-Z score (1.78) which is comparable to the rest of the industry.
MEG has a debt to FCF ratio of 4.96. This is a neutral value as MEG would need 4.96 years to pay back of all of its debts.
MEG has a Debt to FCF ratio of 4.96. This is in the better half of the industry: MEG outperforms 70.24% of its industry peers.
MEG has a Debt/Equity ratio of 0.55. This is a neutral value indicating MEG is somewhat dependend on debt financing.
MEG has a Debt to Equity ratio (0.55) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 4.96
Altman-Z 1.78
ROIC/WACCN/A
WACC8.48%
MEG Yearly LT Debt VS Equity VS FCFMEG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

MEG has a Current Ratio of 1.78. This is a normal value and indicates that MEG is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of MEG (1.78) is better than 61.90% of its industry peers.
MEG has a Quick Ratio of 1.76. This is a normal value and indicates that MEG is financially healthy and should not expect problems in meeting its short term obligations.
MEG has a Quick ratio of 1.76. This is in the better half of the industry: MEG outperforms 72.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.76
MEG Yearly Current Assets VS Current LiabilitesMEG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for MEG have decreased by -1.34% in the last year.
MEG shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.79%.
The Revenue has been growing by 24.38% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-1.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%207.69%
Revenue 1Y (TTM)17.79%
Revenue growth 3Y8.42%
Revenue growth 5Y24.38%
Sales Q2Q%35.32%

3.2 Future

The Earnings Per Share is expected to grow by 27.32% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 13.01% on average over the next years. This is quite good.
EPS Next Y92.69%
EPS Next 2Y38.56%
EPS Next 3Y27.32%
EPS Next 5YN/A
Revenue Next Year15.18%
Revenue Next 2Y9.55%
Revenue Next 3Y12.56%
Revenue Next 5Y13.01%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MEG Yearly Revenue VS EstimatesMEG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
MEG Yearly EPS VS EstimatesMEG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

MEG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MEG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MEG Price Earnings VS Forward Price EarningsMEG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

MEG's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. MEG is more expensive than 64.29% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MEG indicates a somewhat cheap valuation: MEG is cheaper than 73.81% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.66
EV/EBITDA 32.45
MEG Per share dataMEG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

MEG's earnings are expected to grow with 27.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.56%
EPS Next 3Y27.32%

More info and screens

0

5. Dividend

5.1 Amount

MEG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONTROSE ENVIRONMENTAL GROUP

NYSE:MEG (8/25/2025, 8:04:01 PM)

After market: 29.36 0 (0%)

29.36

-0.69 (-2.3%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04
Inst Owners105.66%
Inst Owner Change-0.68%
Ins Owners7.12%
Ins Owner Change0.44%
Market Cap1.04B
Analysts78
Price Target31.37 (6.85%)
Short Float %10.29%
Short Ratio7.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.34
Dividend Growth(5Y)N/A
DP-16.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)144.11%
Min EPS beat(2)-30.65%
Max EPS beat(2)318.86%
EPS beat(4)1
Avg EPS beat(4)-24.22%
Min EPS beat(4)-313.73%
Max EPS beat(4)318.86%
EPS beat(8)2
Avg EPS beat(8)-26.02%
EPS beat(12)2
Avg EPS beat(12)-37.32%
EPS beat(16)4
Avg EPS beat(16)-40.44%
Revenue beat(2)2
Avg Revenue beat(2)14.04%
Min Revenue beat(2)4.73%
Max Revenue beat(2)23.35%
Revenue beat(4)2
Avg Revenue beat(4)5.82%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)23.35%
Revenue beat(8)4
Avg Revenue beat(8)3.07%
Revenue beat(12)5
Avg Revenue beat(12)1.45%
Revenue beat(16)9
Avg Revenue beat(16)2.82%
PT rev (1m)2.5%
PT rev (3m)7.16%
EPS NQ rev (1m)100%
EPS NQ rev (3m)100%
EPS NY rev (1m)84.05%
EPS NY rev (3m)85.19%
Revenue NQ rev (1m)3.77%
Revenue NQ rev (3m)3.64%
Revenue NY rev (1m)5.79%
Revenue NY rev (3m)5.99%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.33
P/FCF 17.66
P/OCF 14.64
P/B 2.06
P/tB N/A
EV/EBITDA 32.45
EPS(TTM)-1.51
EYN/A
EPS(NY)-0.18
Fwd EYN/A
FCF(TTM)1.66
FCFY5.66%
OCF(TTM)2.01
OCFY6.83%
SpS22.11
BVpS14.28
TBVpS-2.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.95%
ROE -9.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.19%
FCFM 7.52%
ROA(3y)-6.43%
ROA(5y)-8.4%
ROE(3y)-11.31%
ROE(5y)-15.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.16%
GM growth 5Y5.98%
F-Score5
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 4.96
Debt/EBITDA 6.7
Cap/Depr 22.12%
Cap/Sales 1.55%
Interest Coverage N/A
Cash Conversion 171.19%
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.76
Altman-Z 1.78
F-Score5
WACC8.48%
ROIC/WACCN/A
Cap/Depr(3y)46.06%
Cap/Depr(5y)35.19%
Cap/Sales(3y)3.51%
Cap/Sales(5y)2.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%207.69%
EPS Next Y92.69%
EPS Next 2Y38.56%
EPS Next 3Y27.32%
EPS Next 5YN/A
Revenue 1Y (TTM)17.79%
Revenue growth 3Y8.42%
Revenue growth 5Y24.38%
Sales Q2Q%35.32%
Revenue Next Year15.18%
Revenue Next 2Y9.55%
Revenue Next 3Y12.56%
Revenue Next 5Y13.01%
EBIT growth 1Y27.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year865.31%
EBIT Next 3Y135.77%
EBIT Next 5Y76.48%
FCF growth 1Y212.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.11%
OCF growth 3Y-16.05%
OCF growth 5Y5.47%